✦ LIBER ✦

Role of surrogate end points in the evaluation of drugs for heart failure

✍ Scribed by Raymond John Lipicky; Milton Packer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biomarkers and Surrogate End Points for

✍ Wagner, J A; Williams, S A; Webster, C J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

Validation of surrogate end points in mu

✍ Tomasz Burzykowski; Geert Molenberghs; Marc Buyse; Helena Geys; Didier Renard 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

Hemodynamics as surrogate end points for

✍ Monica R. Shah; Sandra S. Stinnett; Steven E. McNulty; Mihai Gheorghiade; Faiez 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Proposal for a new clinical end point to

✍ Milton Packer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 47 KB

The Value, Qualification, and Regulatory

✍ Lathia, CD; Amakye, D; Dai, W; Girman, C; Madani, S; Mayne, J; MacCarthy, P; Per 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 225 KB

Statistical methods for clinical studies

✍ Denis Heng-Yan Leung 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB